John Dobak is Chief Executive Officer of DermTech, Inc.. Currently has a direct ownership of 698,693 shares of DMTK, which is worth approximately $27,947. The most recent transaction as insider was on Mar 13, 2023, when has been sold 1,559 shares (Common Stock) at a price of $3.26 per share, resulting in proceeds of $5,082. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 699K
0% 3M change
0% 12M change
Total Value Held $27,947

John Dobak Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 13 2023
SELL
Open market or private sale
$5,082 $3.26 p/Share
1,559 Reduced 0.22%
698,693 Common Stock
Mar 09 2023
BUY
Grant, award, or other acquisition
-
56,407 Added 7.45%
700,252 Common Stock
Mar 07 2023
SELL
Open market or private sale
$97,257 $4.06 p/Share
23,955 Reduced 3.59%
643,845 Common Stock
May 27 2022
BUY
Exercise of in-the-money or at-the-money derivatives securities
$9,957 $1.08 p/Share
9,219 Added 1.37%
665,295 Common Stock
Mar 25 2022
BUY
Grant, award, or other acquisition
-
209,527 Added 24.21%
656,076 Common Stock
Mar 11 2022
SELL
Open market or private sale
$19,293 $14.55 p/Share
1,326 Reduced 0.3%
446,549 Common Stock
Mar 08 2022
SELL
Open market or private sale
$9,935 $12.64 p/Share
786 Reduced 0.18%
447,875 Common Stock
Mar 07 2022
SELL
Open market or private sale
$33,370 $13.03 p/Share
2,561 Reduced 0.57%
448,661 Common Stock
Dec 13 2021
SELL
Open market or private sale
$32,818 $16.71 p/Share
1,964 Reduced 0.43%
450,562 Common Stock
Dec 08 2021
SELL
Open market or private sale
$20,657 $18.46 p/Share
1,119 Reduced 0.25%
452,526 Common Stock
Sep 13 2021
SELL
Open market or private sale
$68,725 $36.19 p/Share
1,899 Reduced 0.42%
453,645 Common Stock
Sep 08 2021
SELL
Open market or private sale
$42,053 $36.19 p/Share
1,162 Reduced 0.25%
455,544 Common Stock
Jul 01 2021
SELL
Open market or private sale
$515,250 $41.22 p/Share
12,500 Reduced 2.67%
456,347 Common Stock
Jun 11 2021
SELL
Open market or private sale
$314,303 $41.08 p/Share
7,651 Reduced 1.61%
468,847 Common Stock
Jun 08 2021
SELL
Open market or private sale
$48,555 $43.43 p/Share
1,118 Reduced 0.23%
476,498 Common Stock
Jun 02 2021
SELL
Open market or private sale
$381,200 $40.0 p/Share
9,530 Reduced 1.96%
477,616 Common Stock
Jun 01 2021
SELL
Open market or private sale
$119,453 $40.22 p/Share
2,970 Reduced 0.61%
487,146 Common Stock
May 03 2021
SELL
Open market or private sale
$1,037,500 $41.5 p/Share
25,000 Reduced 4.85%
490,116 Common Stock
Apr 27 2021
SELL
Open market or private sale
$1,283,750 $51.35 p/Share
25,000 Reduced 4.63%
515,116 Common Stock
Apr 12 2021
SELL
Open market or private sale
$1,172,000 $46.88 p/Share
25,000 Reduced 4.42%
540,116 Common Stock
Mar 29 2021
BUY
Grant, award, or other acquisition
-
29,195 Added 4.91%
565,116 Common Stock
Mar 18 2021
SELL
Payment of exercise price or tax liability
$381,452 $53.35 p/Share
7,150 Reduced 1.32%
535,921 Common Stock
Mar 08 2021
SELL
Open market or private sale
$39,031 $50.04 p/Share
780 Reduced 0.14%
543,071 Common Stock
Dec 08 2020
SELL
Open market or private sale
$9,322 $11.86 p/Share
786 Reduced 0.14%
541,683 Common Stock
JD

John Dobak

Chief Executive Officer
La Jolla, CA

Track Institutional and Insider Activities on DMTK

Follow DermTech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DMTK shares.

Notify only if

Insider Trading

Get notified when an Derm Tech, Inc. insider buys or sells DMTK shares.

Notify only if

News

Receive news related to DermTech, Inc.

Track Activities on DMTK